{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:56:40Z","timestamp":1759694200970,"version":"3.41.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.mehy.2018.04.010","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T06:28:19Z","timestamp":1523514499000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Treatment of anorexia nervosa with palmitoylethanoamide"],"prefix":"10.1016","volume":"116","author":[{"given":"Barbara","family":"Scolnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington; 2013.","key":"10.1016\/j.mehy.2018.04.010_b0005","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.mehy.2018.04.010_b0010","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrn2682","article-title":"New insights into symptoms and neurocircuit function of anorexia nervosa","volume":"10","author":"Kaye","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2018.04.010_b0015","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(99)05363-5","article-title":"Long term prognosis in anorexia nervosa: lessons from a 21 year follow up study","volume":"355","author":"Zipfel","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/eat.20670","article-title":"2010 Substance use disorders in women with anorexia nervosa","volume":"43","author":"Root","year":"2010","journal-title":"Int J Eat Disord"},{"issue":"5","key":"10.1016\/j.mehy.2018.04.010_b0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1037\/0012-1649.37.5.608","article-title":"Relation of early menarche to depression, eating disorders, substance abuse, and comorbid psychopathology among adolescent girls","volume":"37","author":"Stice","year":"2001","journal-title":"Dev Psychol"},{"issue":"3","key":"10.1016\/j.mehy.2018.04.010_b0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","article-title":"2007 The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication","volume":"61","author":"Hudson","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.mehy.2018.04.010_b0035","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1176\/appi.ajp.159.8.1284","article-title":"The outcome of anorexia nervosa in the 20th century","volume":"159","author":"Steinhausen","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.mehy.2018.04.010_b0040","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/archgenpsychiatry.2011.74","article-title":"Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies","volume":"68","author":"Arcelus","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2018.04.010_b0045","first-page":"1073","article-title":"Mortality in anorexia nervosa","volume":"15297","author":"Sullivan","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mehy.2018.04.010_b0050","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/HYPERTENSIONAHA.105.063651","article-title":"Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations","volume":"52","author":"Pacher","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2018.04.010_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00281-009-0145-8","article-title":"The emerging role of the endocannabinoid system in cardiovascular disease","volume":"31","author":"Pacher","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.mehy.2018.04.010_b0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2018.04.010_b0065","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1152\/ajpgi.00467.2007","article-title":"Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver","volume":"294","author":"Mallat","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.mehy.2018.04.010_b0070","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","article-title":"CB receptors as new therapeutic targets for liver diseases","volume":"153","author":"Lotersztajn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0075","doi-asserted-by":"crossref","first-page":"G850","DOI":"10.1152\/ajpgi.00523.2007","article-title":"Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases","volume":"294","author":"Pacher","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.mehy.2018.04.010_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.freeradbiomed.2009.11.022","article-title":"Cannabinoid-2 receptor limits inflammation, oxidative\/nitrosative stress, and cell death in nephropathy","volume":"48","author":"Mukhopadhyay","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mehy.2018.04.010_b0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.tips.2007.02.004","article-title":"The endocannabinoid system in targeting inflammatory neurodegenerative diseases","volume":"28","author":"Centonze","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2018.04.010_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB receptor: a new target for controlling neural cell survival?","volume":"28","author":"Fernandez-Ruiz","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2018.04.010_b0095","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1476-5381.2008.00088.x","article-title":"The endocannabinoid system as a target for the treatment of motor dysfunction","volume":"156","author":"Fernandez-Ruiz","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0100","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.biopsych.2009.09.024","article-title":"Brain cannabinoid CB receptor in schizophrenia","volume":"67","author":"Ishiguro","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2018.04.010_b0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1196\/annals.1432.036","article-title":"Functional expression of brain neuronal CB cannabinoid receptors are involved in the effects of drugs of abuse and in depression","volume":"1139","author":"Onaivi","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.mehy.2018.04.010_b0110","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.2010.00819.x","article-title":"Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors","volume":"160","author":"Garcia-Gutierrez","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain Reviews","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garcia-Gutierrez","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.brainresrev.2008.12.003","article-title":"Targeting CB receptors and the endocannabinoid system for the treatment of pain","volume":"60","author":"Anand","year":"2009","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.mehy.2018.04.010_b0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.bjp.0707531","article-title":"Cannabinoid CB Receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain","volume":"153","author":"Guindon","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc1188","article-title":"Cannabinoids: potential anticancer agents","volume":"3","author":"Guzman","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.mehy.2018.04.010_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phrs.2009.03.011","article-title":"Endocannabinoid system modulation in cancer biology and therapy","volume":"60","author":"Pisanti","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2018.04.010_b0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.2174\/156802610791164201","article-title":"Targeting the endocannabinoid system for the treatment of cancer \u2013 a practical view","volume":"10","author":"Fowler","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.mehy.2018.04.010_b0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bjp.0707444","article-title":"CB receptors in reproduction","volume":"153","author":"Maccarrone","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.bjp.0707593","article-title":"Cannabinoid receptors and the regulation of bone mass","volume":"153","author":"Bab","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0160","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/07853890903121025","article-title":"Cannabinoids and the skeleton: from marijuana to reversal of bone loss","volume":"41","author":"Bab","year":"2009","journal-title":"Ann Med"},{"key":"10.1016\/j.mehy.2018.04.010_b0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tips.2009.05.004","article-title":"The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities","volume":"30","author":"Biro","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mehy.2018.04.010_b0170","series-title":"Cannabinoids as Therapeutic Agents","first-page":"1","article-title":"The pharmacohistory of Cannabis sativa","author":"Mechoulam","year":"1986"},{"key":"10.1016\/j.mehy.2018.04.010_b0175","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mehy.2018.04.010_b0180","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1021\/ja00993a072","article-title":"A stereospecific synthesis of tetrhydrocannabinoids","volume":"89","author":"Mechoulam","year":"1967","journal-title":"J Am Chem Soci"},{"key":"10.1016\/j.mehy.2018.04.010_b0185","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0190","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2018.04.010_b0200","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.mehy.2018.04.010_b0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"issue":"2 & 3","key":"10.1016\/j.mehy.2018.04.010_b0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1054\/plef.2001.0347","article-title":"The endocannabinoid system in invertebrates","volume":"66","author":"Salzet","year":"2002","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"10.1016\/j.mehy.2018.04.010_b0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2018.04.010_b0220","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","article-title":"CB a cannabinoid receptor with an identity crisis","volume":"160","author":"Atwood","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2018.04.010_b0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.mehy.2018.04.010_b0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bjp.0707527","article-title":"The peripheral cannabinoid receptor knockout mice: an update","volume":"153","author":"Buckley","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.plipres.2011.01.001","article-title":"Is lipid signaling through cannabinoid 2 receptors part of a protective system","volume":"50","author":"Pacher","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.mehy.2018.04.010_b0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/bjp.2008.324","article-title":"\u201cEntourage\u201d effect of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxtion to anandamide occur through TRPV1 receptors","volume":"155","author":"Ho","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0250","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1074\/jbc.272.6.3315","article-title":"Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamde in leukocytes","volume":"272","author":"Bisogno","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2018.04.010_b0255","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid e-caramoyl-biphenyl-3 ester L effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"Fegley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0265","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2018.04.010_b0270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating; mediation by central CB1 receptors","volume":"143","author":"William","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.mehy.2018.04.010_b0275","first-page":"424","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"373","author":"Zhang","year":"1994","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/oby.2009.228","article-title":"Leptin and the control of body weight; a review of it diverse central targets, signaling mechanisms and role in the pathogenesis of obesity","volume":"18","author":"Oswal","year":"2010","journal-title":"Obesity"},{"issue":"6762","key":"10.1016\/j.mehy.2018.04.010_b0285","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kohima","year":"1999","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mehy.2018.04.010_b0290","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1096\/fj.03-0641rev","article-title":"Ghrelin, appetite, an gastric motility: the emerging role of the stomach as an endocrine organ","volume":"18","author":"Onui","year":"2004","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1440-1681.2009.05241.x","article-title":"Ghrelin gene-related peptides: multifunctional endocrine\/autocrine modulators in health and disease","volume":"37","author":"Seim","year":"2010","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.mehy.2018.04.010_b0300","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mehy.2018.04.010_b0305","doi-asserted-by":"crossref","first-page":"e1797","DOI":"10.1371\/journal.pone.0001797","article-title":"The orexigneic effect of ghrelin is mediated through central activation of the endocannabionoid system","volume":"3","author":"Kola","year":"2008","journal-title":"PLoSOne"},{"issue":"4","key":"10.1016\/j.mehy.2018.04.010_b0310","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-15-0875","article-title":"2016 Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum","volume":"174","author":"Baskaran","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.chc.2008.07.002","article-title":"Leptin mediated neuroendocrine alterations in anorexia nervosa: somatic and behavioral implications","volume":"18","author":"Muller","year":"2009","journal-title":"Child Adolesc Pscychiatr Clin N Am"},{"issue":"5","key":"10.1016\/j.mehy.2018.04.010_b0320","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-1450669","article-title":"Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa","volume":"145","author":"Otoo","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0325","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cmet.2012.01.002","article-title":"2012 Challenges and opportunities of defining clinical leptin resistance","volume":"15","author":"Myers","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.mehy.2018.04.010_b0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000346058","article-title":"Ghrelin reward and motivation","volume":"25","author":"Menzies","year":"2013","journal-title":"Endocr Dev"},{"issue":"6","key":"10.1016\/j.mehy.2018.04.010_b0335","doi-asserted-by":"crossref","first-page":"E917","DOI":"10.1210\/jc.2011-3018","article-title":"Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannainoid 2 \u2013arachidonoyl-glycerol in health humans a pilot study","volume":"97","author":"Montelone","year":"2012","journal-title":"J Clinic Endocrinol Metab"},{"key":"10.1016\/j.mehy.2018.04.010_b0340","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1300695","article-title":"Blood levels of the endocannainoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa","volume":"30","author":"Monteleone","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0345","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3945\/ajcn.114.096164","article-title":"Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa","volume":"101","author":"Monteleone","year":"2015","journal-title":"AmJ Clin Nutr"},{"key":"10.1016\/j.mehy.2018.04.010_b0350","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature01921","article-title":"Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha","volume":"425","author":"Fu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2018.04.010_b0355","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/sj.npp.1300166","article-title":"Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide","volume":"28","author":"Gaetani","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2018.04.010_b0360","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35102582","article-title":"An anorexic lipid mediator regulated by feeding","volume":"414","author":"Rodriguez de Fonseca","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mehy.2018.04.010_b0365","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/en.2013-1823","article-title":"Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats","volume":"155","author":"Raso","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saitiel","year":"2017","journal-title":"J Clin Invest."},{"key":"10.1016\/j.mehy.2018.04.010_b0375","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.psyneuen.2014.09.031","article-title":"Correll CU Inflammatory cytokines and anorexia nervosa: a meta-analysis of cross sectional and longitudinal studies","volume":"51","author":"Solmi","year":"2015","journal-title":"Psychoneurolendocrinology"},{"issue":"6","key":"10.1016\/j.mehy.2018.04.010_b0380","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-440X(97)90927-5","article-title":"The prevalence of high-level exercise in the eating disorders: etiological implications","volume":"38","author":"Davis","year":"1997","journal-title":"Compr Psychiatry"},{"issue":"4","key":"10.1016\/j.mehy.2018.04.010_b0385","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1037\/0033-295X.110.4.745","article-title":"Adapted to flee famine; adding an evolutionary perspective on anorexia nervosa","volume":"110","author":"Guisinger","year":"2003","journal-title":"Psycholog Rev"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0390","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/00913847.1982.11947169","article-title":"Endorphins and exercise: a puzzling relationship","volume":"10","author":"Moore","year":"1982","journal-title":"Phys Sports Med"},{"key":"10.1016\/j.mehy.2018.04.010_b0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1514996112","article-title":"A runners high depends on cannabinoid receptors in mice","author":"Fuss","year":"2015","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0400","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0195-6663(88)90063-3","article-title":"Fat aversion in eating disorders","volume":"10","author":"Drewnowki","year":"1988","journal-title":"Appetite"},{"key":"10.1016\/j.mehy.2018.04.010_b0405","doi-asserted-by":"crossref","first-page":"443","DOI":"10.33549\/physiolres.930643","article-title":"Composition of plasma fatty acids and non-cholesterol sterols in anorexia nervosa","volume":"54","author":"Zak","year":"2005","journal-title":"Physiol Res"},{"key":"10.1016\/j.mehy.2018.04.010_b0410","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1651-2227.2011.02400.x","article-title":"Essential fatty acid status in teenage girls with eating disorders and weight loss","volume":"100","author":"Swenne","year":"2011","journal-title":"Acta Paediatri"},{"issue":"2","key":"10.1016\/j.mehy.2018.04.010_b0415","first-page":"159","article-title":"Serum lipids in anorexia nervosa","volume":"8","author":"Halmi","year":"1974","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mehy.2018.04.010_b0420","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2362.2004.01415.x","article-title":"Chemical physical properties of lipoproteins in anorexia nervosa","volume":"34","author":"Curatola","year":"2005","journal-title":"Eur J Clini Invest"},{"key":"10.1016\/j.mehy.2018.04.010_b0425","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jn\/125.4.901","article-title":"Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acid, compensatory changes in nonessential fatty acids, and decreased fluidity of plasma lipids","volume":"125","author":"Holman","year":"1995","journal-title":"J Nutr"},{"issue":"4","key":"10.1016\/j.mehy.2018.04.010_b0430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/mp.2015.26","article-title":"Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa","volume":"21","author":"Shih","year":"2016","journal-title":"Mol Psychiatry."},{"issue":"5548","key":"10.1016\/j.mehy.2018.04.010_b0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.mehy.2018.04.010_b0440","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1074\/jbc.M313258200","article-title":"On the evolutionary origin of cyclooxygenase (COS) isoenzymes; characterization of marine invertebrate COX genes points to independent duplication events in vertebrate and invertebrate lineages","volume":"279","author":"Harving","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2018.04.010_b0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF01861161","article-title":"Information on the pharmacological effect of natural secretions and extracts from male accessory sexual glands","volume":"175","author":"Euler","year":"1934","journal-title":"Arch Exp Pathol Pharm"},{"issue":"13","key":"10.1016\/j.mehy.2018.04.010_b0450","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1074\/jbc.X112.351437","article-title":"Role of basic science in the development of new medicines; examples from the eicosanoid field","volume":"287","author":"Samuelsson","year":"2012","journal-title":"Reflections J Biolog Chem"},{"unstructured":"Announcement from The Nobel Assembly of Karolinska Institute Oct 11, 1982. Nobel Prize in Physiology or Medicine to Sune K Bergstrom, Bengt I. Samuelsson and John R. Vane found at https:\/\/www.nobelprize.org\/nobel_prizes\/medicine\/laureates\/1982\/press.html.","key":"10.1016\/j.mehy.2018.04.010_b0455"},{"key":"10.1016\/j.mehy.2018.04.010_b0460","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mehy.2018.04.010_b0465","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1037\/h0025205","article-title":"Self starvation of rats living in activity wheels on a restricted feeding schedule","volume":"64","author":"Routtenberg","year":"1967","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.mehy.2018.04.010_b0470","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1111\/bph.13892","article-title":"Cannabinoid CB1\/CB2 receptor agonist attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia","volume":"174","author":"Scherma","year":"2017","journal-title":"British J Pharmacol"},{"key":"10.1016\/j.mehy.2018.04.010_b0475","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/npp.2011.19","article-title":"The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia","volume":"36","author":"Verty","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.mehy.2018.04.010_b0480","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/ja01577a066","article-title":"The identification of N (2 hydroxyethyl) palmitamide as a naturally occurring anti-inflamatory agent","volume":"79","author":"Kuehl","year":"1957","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.mehy.2018.04.010_b0485","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/JPR.S48653","article-title":"Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR alpha agonist and effective nutraceutical","volume":"6","author":"Hesselink","year":"2013","journal-title":"J Pain Res"},{"key":"10.1016\/j.mehy.2018.04.010_b0490","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0006-8993(77)90772-7","article-title":"Mast cells increase in tissues of neonatal rats injected with the nerve growth factor","volume":"133","author":"Aloe","year":"1977","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2018.04.010_b0495","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2014.05.006","article-title":"Review Palmitoylehanolamide in CNS health and disease","volume":"86","author":"Rasso","year":"2014","journal-title":"Pharmacolog Res"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0500","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","article-title":"Cannabinoids in the management of difficult to treat pain","volume":"4","author":"Russo","year":"2008","journal-title":"Therapeutics Clin Risk Manage"},{"key":"10.1016\/j.mehy.2018.04.010_b0505","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/02791072.1998.10399689","article-title":"Abuse potential of dronabinol (Marinol)","volume":"30","author":"Calhoun","year":"1998","journal-title":"J Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.mehy.2018.04.010_b0510","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/eat.22173","article-title":"Dronabinol in severe enduring anorexia nervosa: a randomized controlled trial","volume":"47","author":"Andries","year":"2014","journal-title":"Int J Eat Disord"},{"key":"10.1016\/j.mehy.2018.04.010_b0515","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432607","article-title":"Ghatei; Rimonabant: From RIO (Rimonabant in Obesity Trials) to Ban","author":"Sam","year":"2011","journal-title":"J Obesity"},{"key":"10.1016\/j.mehy.2018.04.010_b0520","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1367-5931(03)00079-6","article-title":"Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system","volume":"7","author":"Cravatt","year":"2003","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.mehy.2018.04.010_b0525","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Derbrat","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.mehy.2018.04.010_b0530","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aaf7497","article-title":"Activity based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10\u20132472","volume":"356","author":"van Esbroeck","year":"2017","journal-title":"Science"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718302020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718302020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T16:14:24Z","timestamp":1751559264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718302020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":106,"alternative-id":["S0306987718302020"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2018.04.010","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of anorexia nervosa with palmitoylethanoamide","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2018.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}